Long-term cytokine-free expansion of cord blood mononuclear cells in three-dimensional scaffolds

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9263-9270

  Mortera Blanco, Teresa ^a   Mantalaris, Athanasios ^a   Bismarck, Alexander ^a   Aqel, Nayef ^b   Panoskaltsis, Nicki ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

Biomimetic biomaterials; Bone marrow tissue engineering; Cord blood stem cells; Cytokine free

Indexed keywords

3-D CULTURE SYSTEM; BIOMIMETIC GROWTH; BONE MARROW TISSUE ENGINEERING; CELL DIFFERENTIATION; COLLAGEN TYPE I; COLONY FORMING UNITS; CORD BLOOD; CORD BLOOD STEM CELLS; CULTURE SYSTEMS; CYTOKINE-FREE; CYTOKINES; DRUG DISCOVERY; EX-VIVO; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM/PROGENITOR CELLS; LIQUID SUSPENSION; LONG-TERM CULTURE; MYELOID CELLS; POLY(D ,L-LACTIDE-CO-GLYCOLIDE); POROUS SCAFFOLD; T-LYMPHOCYTES; THERAPEUTIC APPLICATION; THREE-DIMENSIONAL (3D) ENVIRONMENTS; THREE-DIMENSIONAL SCAFFOLDS;

BIOMIMETICS; BLOOD; CELL CULTURE; EXPANSION; ORGANIC POLYMERS; SCANNING ELECTRON MICROSCOPY; STEM CELLS; THREE DIMENSIONAL; TISSUE;

SCAFFOLDS (BIOLOGY);

COLLAGEN TYPE 1; POLYGLACTIN; POLYURETHAN;

ARTICLE; BONE MARROW CELL; BURST FORMING UNIT E; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONING; CELL CULTURE; CELL EXPANSION; CELL GROWTH; CELL PROLIFERATION; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CORD BLOOD MONONUCLEAR CELL; ERYTHROID PRECURSOR CELL; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MEGAKARYOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; THREE DIMENSIONAL CULTURE SYSTEM;

CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; CLONE CELLS; CYTOKINES; FETAL BLOOD; HUMANS; IMMUNOPHENOTYPING; LACTIC ACID; LEUKOCYTES, MONONUCLEAR; POLYGLYCOLIC ACID; POLYURETHANES; TIME FACTORS; TISSUE SCAFFOLDS;

EID: 80053601062     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.051     Document Type: Article

References (33)

1. Kelly S., Sola C., de Lima M., Shpall E. Ex vivo expansion of cord blood. Bone Marrow Transplant 2009, 44(10):673-681.
2. Lee O., Kuo T., Chen W., Lee K., Hsieh S., Chen T. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004, 103(5):1669-1675.
3. Piacibello W., Sanavio F., Garetto L., Severino A., Dane A., Gammaitoni L., et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998, 12(5):718-727.
4. Koller M., Manchel I., Maher R., Goltry K., Armstrong R., Smith A. Clinical-scale human umbilical cord blood cell expansion in a novel automated perfusion culture system. Bone Marrow Transplant 1998, 21(7):653-663.
5. Engelhardt M., Douville J., Behringer D., Jahne A., Smith A., Henschler R., et al. Hematopoietic recovery of ex vivo perfusion culture expanded bone marrow and unexpanded peripheral blood progenitors after myeloablative chemotherapy. Bone Marrow Transplant 2001, 27(3):249-259.
6. Kirito K., Fox N., Kaushansky K. Thrombopoietin stimulates Hoxb4 expression: an explanation for the favorable effects of TPO on hematopoietic stem cells. Blood 2003, 102(9):3172-3178.
7. Lyman S., Eirik S., Jacobsen W. c-kit Ligand and Flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998, 91:1101-1134.
8. Levac K., Karanu F., Bhatia M. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo. Haematologica 2005, 90(2):166-172.
9. Rabinowitz J., Petros W., Stuart A., Peters W. Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support. Blood 1993, 81(9):2452-2459.
10. Panoskaltsis N., Mantalaris A., Wu D. Engineering a mimicry of bone marrow tissue ex vivo. J Biosci Bioeng 2005, 100(1):28-35.
11. Klein G. The extracellular matrix of the hematopoietic microenvironment. Cell Mol Life Sci 1995, 51(9):914-926.
12. Mantalaris A., Bourne P., Wu J. Production of human osteoclasts in a three-dimensional bone marrow culture system. Biochem Eng J 2004, 20(2-3):189-196.
13. Fisher O., Khademhosseini A., Langer R., Peppas N. Bioinspired materials for controlling stem cell fate. Acc Chem Res 2010, 43(3):419-429.
14. Bagley J., Rosenzweig M., Marks D., Pykett M. Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device. Exp Hematol 1999, 27(3):496-504.
15. Banu N., Rosenzweig M., Kim H., Bagley J., Pykett M. Cytokine-augmented culture of haematopoietic progenitor cells in a novel three-dimensional cell growth matrix. Cytokine 2001, 13(6):349-358.
16. Mantalaris A., Keng P., Bourne P., Chang A., Wu J. Engineering a human bone marrow model: a case study on ex vivo erythropoiesis. Biotechnol Prog 1998, 14(1):126-133.
17. Wang T., Brennan J., Wu D. Multilineage hematopoiesis in a three-dimensional murine long-term bone marrow culture. Exp Hematol 1995, 23(1):23-32.
18. Mortera-Blanco T., Mantalaris A., Bismarck A., Panoskaltsis N. The development of a three-dimensional scaffold for ex vivo biomimicry of human acute myeloid leukaemia. Biomaterials 2010, 31(8):2243-2251.
19. Battista S., Guarnieri D., Borselli C., Zeppetelli S., Borzacchiello A., Mayol L., et al. The effect of matrix composition of 3D constructs on embryonic stem cell differentiation. Biomaterials 2005, 26(31):6194-6207.
20. Safinia L., Mantalaris A., Bismarck A. Nondestructive technique for the characterization of the pore size distribution of soft porous constructs for tissue engineering. Langmuir 2006, 22(7):3235-3242.
21. Safinia L., Datan N., Hohse M., Mantalaris A., Bismarck A. Towards a methodology for the effective surface modification of porous polymer scaffolds. Biomaterials 2005, 26(36):7537-7547.
22. Miller C., Lai B. Human and mouse hematopoietic colony-forming cell assays. Basic Cell Culture Protocols 3, Methods in Molecular Biology 2005, 71-89. Humana Press, Totowa, NJ. C. Helgason, C. Miller (Eds.).
23. Wilson A., Trumpp A. Bone marrow haematopoietic stem cell niches. Nat Rev Immunol 2006, 6:93-106.
24. Zeltinger J., Sherwood J., Graham D., Mueller R., Griffith L. Effect of pore size and void fraction on cellular adhesion, proliferation, and matrix deposition. Tissue Eng 2001, 7(5):557-572.
25. Lee J., Khang G., Lee J., Lee H. Interaction of different types of cells on polymer surfaces with wettability gradient. J Colloid Interface Sci 1998, 205(2):323-330.
26. Vanwachem P., Beugeling T., Feijen J., Bantjes A., Detmers J., Vanaken W. Interaction of cultured human-endothelial cells with polymeric surfaces of different wettabilities. Biomaterials 1985, 6(6):403-408.
27. Dunn M., Bellincampi L., Tria A., Zawadsky J. Preliminary development of a collagen-PLA composite for ACL reconstruction. J Appl Polym Sci Symp 1997, 63(11):1423-1428.
28. Kaufmann P., Heimrath S., Kim B., Mooney D. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant 1997, 6(5):463-468.
29. Geissler U., Hempel U., Wolf C., Scharnweber D., Worch H., Wenzel K. Collagen type I-coating of Ti6Al4V promotes adhesion of osteoblasts. J Biomed Mater Res 2000, 51(4):752-760.
30. Shpall E., Quinones R., Giller R., Zeng C., Baron A., Jones R., et al. Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant 2002, 8(7):368-376.
31. McNiece I., Kubegov D., Kerzic P., Shpall E., Gross S. Increased expansion and differentiation of cord blood products using a two-step expansion culture. Exp Hematol 2000, 28(10):1181-1186.
32. de Lima M., McMannis J., Gee A., Komanduri K., Couriel D., Andersson B., et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 2008, 41(9):771-778.
33. Delaney C., Heimfeld S., Brashem-Stein C., Voorhies H., Manger R., Bernstein I. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010, 16(2):232-237.